nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Rivaroxaban—ABCB1—colon cancer	0.0295	1	CrCbGaD
Linezolid—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00564	0.00581	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.0054	0.00556	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00521	0.00537	CcSEcCtD
Linezolid—Hypokalaemia—Irinotecan—colon cancer	0.00513	0.00529	CcSEcCtD
Linezolid—Cramp muscle—Irinotecan—colon cancer	0.00508	0.00523	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00508	0.00523	CcSEcCtD
Linezolid—Fungal infection—Methotrexate—colon cancer	0.00501	0.00516	CcSEcCtD
Linezolid—Skin ulcer—Methotrexate—colon cancer	0.00497	0.00512	CcSEcCtD
Linezolid—Candida infection—Capecitabine—colon cancer	0.00496	0.00511	CcSEcCtD
Linezolid—Fluid retention—Capecitabine—colon cancer	0.00493	0.00508	CcSEcCtD
Linezolid—Neuropathy—Capecitabine—colon cancer	0.00488	0.00503	CcSEcCtD
Linezolid—Pancreatitis—Irinotecan—colon cancer	0.00478	0.00492	CcSEcCtD
Linezolid—Pancytopenia—Vincristine—colon cancer	0.00475	0.00489	CcSEcCtD
Linezolid—Sweating increased—Irinotecan—colon cancer	0.00475	0.00489	CcSEcCtD
Linezolid—Ecchymosis—Capecitabine—colon cancer	0.0047	0.00484	CcSEcCtD
Linezolid—Urine output increased—Capecitabine—colon cancer	0.0047	0.00484	CcSEcCtD
Linezolid—Neutropenia—Vincristine—colon cancer	0.00468	0.00482	CcSEcCtD
Linezolid—Eosinophilia—Fluorouracil—colon cancer	0.00462	0.00476	CcSEcCtD
Linezolid—Apnoea—Methotrexate—colon cancer	0.00456	0.0047	CcSEcCtD
Linezolid—Neutropenia—Irinotecan—colon cancer	0.00456	0.00469	CcSEcCtD
Linezolid—Upper respiratory tract infection—Irinotecan—colon cancer	0.00453	0.00467	CcSEcCtD
Linezolid—Sepsis—Capecitabine—colon cancer	0.00451	0.00465	CcSEcCtD
Linezolid—Pneumonia—Vincristine—colon cancer	0.00449	0.00462	CcSEcCtD
Linezolid—Pancytopenia—Fluorouracil—colon cancer	0.00443	0.00457	CcSEcCtD
Linezolid—Phlebitis—Capecitabine—colon cancer	0.00438	0.00451	CcSEcCtD
Linezolid—Neuropathy peripheral—Vincristine—colon cancer	0.00437	0.0045	CcSEcCtD
Linezolid—Pneumonia—Irinotecan—colon cancer	0.00437	0.0045	CcSEcCtD
Linezolid—Thrombophlebitis—Capecitabine—colon cancer	0.00436	0.00449	CcSEcCtD
Linezolid—Stomatitis—Vincristine—colon cancer	0.00435	0.00448	CcSEcCtD
Linezolid—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00434	0.00447	CcSEcCtD
Linezolid—Polyuria—Capecitabine—colon cancer	0.0043	0.00443	CcSEcCtD
Linezolid—Renal failure—Irinotecan—colon cancer	0.00427	0.0044	CcSEcCtD
Linezolid—Stomatitis—Irinotecan—colon cancer	0.00423	0.00436	CcSEcCtD
Linezolid—Glossitis—Methotrexate—colon cancer	0.0042	0.00433	CcSEcCtD
Linezolid—Pneumonia—Fluorouracil—colon cancer	0.00418	0.00431	CcSEcCtD
Linezolid—Neuropathy peripheral—Fluorouracil—colon cancer	0.00408	0.0042	CcSEcCtD
Linezolid—Stomatitis—Fluorouracil—colon cancer	0.00405	0.00418	CcSEcCtD
Linezolid—Hypoaesthesia—Vincristine—colon cancer	0.00398	0.0041	CcSEcCtD
Linezolid—Thirst—Capecitabine—colon cancer	0.00396	0.00408	CcSEcCtD
Linezolid—Haemoglobin—Irinotecan—colon cancer	0.00392	0.00404	CcSEcCtD
Linezolid—Haemorrhage—Irinotecan—colon cancer	0.0039	0.00402	CcSEcCtD
Linezolid—Vaginal inflammation—Methotrexate—colon cancer	0.00387	0.00399	CcSEcCtD
Linezolid—Hyponatraemia—Capecitabine—colon cancer	0.00379	0.0039	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00377	0.00389	CcSEcCtD
Linezolid—Haemoglobin—Fluorouracil—colon cancer	0.00375	0.00387	CcSEcCtD
Linezolid—Haemorrhage—Fluorouracil—colon cancer	0.00373	0.00385	CcSEcCtD
Linezolid—Hypoaesthesia—Fluorouracil—colon cancer	0.00372	0.00383	CcSEcCtD
Linezolid—Pharyngitis—Fluorouracil—colon cancer	0.00371	0.00382	CcSEcCtD
Linezolid—Vaginal infection—Methotrexate—colon cancer	0.00365	0.00376	CcSEcCtD
Linezolid—Chills—Irinotecan—colon cancer	0.0035	0.0036	CcSEcCtD
Linezolid—Ecchymosis—Methotrexate—colon cancer	0.0035	0.0036	CcSEcCtD
Linezolid—Urine output increased—Methotrexate—colon cancer	0.0035	0.0036	CcSEcCtD
Linezolid—Liver function test abnormal—Capecitabine—colon cancer	0.00348	0.00359	CcSEcCtD
Linezolid—Hypokalaemia—Capecitabine—colon cancer	0.00343	0.00354	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.0034	0.0035	CcSEcCtD
Linezolid—Sepsis—Methotrexate—colon cancer	0.00336	0.00346	CcSEcCtD
Linezolid—Flatulence—Irinotecan—colon cancer	0.00334	0.00345	CcSEcCtD
Linezolid—Gastritis—Capecitabine—colon cancer	0.00334	0.00344	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00333	0.00343	CcSEcCtD
Linezolid—Muscle spasms—Irinotecan—colon cancer	0.00326	0.00336	CcSEcCtD
Linezolid—Erythema—Fluorouracil—colon cancer	0.00325	0.00335	CcSEcCtD
Linezolid—Thrombophlebitis—Methotrexate—colon cancer	0.00324	0.00334	CcSEcCtD
Linezolid—Anaemia—Vincristine—colon cancer	0.00322	0.00332	CcSEcCtD
Linezolid—Polyuria—Methotrexate—colon cancer	0.0032	0.0033	CcSEcCtD
Linezolid—Sweating increased—Capecitabine—colon cancer	0.00318	0.00327	CcSEcCtD
Linezolid—Anaemia—Irinotecan—colon cancer	0.00314	0.00323	CcSEcCtD
Linezolid—Vertigo—Vincristine—colon cancer	0.00313	0.00323	CcSEcCtD
Linezolid—Leukopenia—Vincristine—colon cancer	0.00312	0.00321	CcSEcCtD
Linezolid—Pancytopenia—Capecitabine—colon cancer	0.0031	0.00319	CcSEcCtD
Linezolid—Vision blurred—Fluorouracil—colon cancer	0.00306	0.00316	CcSEcCtD
Linezolid—Vertigo—Irinotecan—colon cancer	0.00305	0.00314	CcSEcCtD
Linezolid—Neutropenia—Capecitabine—colon cancer	0.00305	0.00314	CcSEcCtD
Linezolid—Leukopenia—Irinotecan—colon cancer	0.00304	0.00313	CcSEcCtD
Linezolid—Upper respiratory tract infection—Capecitabine—colon cancer	0.00303	0.00312	CcSEcCtD
Linezolid—Convulsion—Vincristine—colon cancer	0.00302	0.00311	CcSEcCtD
Linezolid—Hypertension—Vincristine—colon cancer	0.00301	0.0031	CcSEcCtD
Linezolid—Anaemia—Fluorouracil—colon cancer	0.003	0.0031	CcSEcCtD
Linezolid—Cough—Irinotecan—colon cancer	0.00296	0.00305	CcSEcCtD
Linezolid—Hyperglycaemia—Capecitabine—colon cancer	0.00294	0.00303	CcSEcCtD
Linezolid—Hypertension—Irinotecan—colon cancer	0.00293	0.00302	CcSEcCtD
Linezolid—Pneumonia—Capecitabine—colon cancer	0.00292	0.00301	CcSEcCtD
Linezolid—Leukopenia—Fluorouracil—colon cancer	0.00291	0.003	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00288	0.00297	CcSEcCtD
Linezolid—Renal failure—Capecitabine—colon cancer	0.00286	0.00294	CcSEcCtD
Linezolid—Neuropathy peripheral—Capecitabine—colon cancer	0.00285	0.00294	CcSEcCtD
Linezolid—Anaphylactic shock—Vincristine—colon cancer	0.00284	0.00293	CcSEcCtD
Linezolid—Stomatitis—Capecitabine—colon cancer	0.00283	0.00292	CcSEcCtD
Linezolid—Convulsion—Fluorouracil—colon cancer	0.00282	0.0029	CcSEcCtD
Linezolid—Thrombocytopenia—Vincristine—colon cancer	0.00278	0.00287	CcSEcCtD
Linezolid—Anaphylactic shock—Irinotecan—colon cancer	0.00277	0.00285	CcSEcCtD
Linezolid—Hyperhidrosis—Vincristine—colon cancer	0.00275	0.00283	CcSEcCtD
Linezolid—Thrombocytopenia—Irinotecan—colon cancer	0.00271	0.00279	CcSEcCtD
Linezolid—Anorexia—Vincristine—colon cancer	0.00271	0.00279	CcSEcCtD
Linezolid—Hyperhidrosis—Irinotecan—colon cancer	0.00268	0.00276	CcSEcCtD
Linezolid—Anaphylactic shock—Fluorouracil—colon cancer	0.00265	0.00273	CcSEcCtD
Linezolid—Anorexia—Irinotecan—colon cancer	0.00264	0.00272	CcSEcCtD
Linezolid—Haemoglobin—Capecitabine—colon cancer	0.00262	0.0027	CcSEcCtD
Linezolid—Haemorrhage—Capecitabine—colon cancer	0.00261	0.00269	CcSEcCtD
Linezolid—Thrombocytopenia—Fluorouracil—colon cancer	0.0026	0.00268	CcSEcCtD
Linezolid—Hypoaesthesia—Capecitabine—colon cancer	0.0026	0.00268	CcSEcCtD
Linezolid—Liver function test abnormal—Methotrexate—colon cancer	0.00259	0.00267	CcSEcCtD
Linezolid—Pharyngitis—Capecitabine—colon cancer	0.00259	0.00267	CcSEcCtD
Linezolid—Insomnia—Vincristine—colon cancer	0.00257	0.00265	CcSEcCtD
Linezolid—Paraesthesia—Vincristine—colon cancer	0.00255	0.00263	CcSEcCtD
Linezolid—Anorexia—Fluorouracil—colon cancer	0.00253	0.00261	CcSEcCtD
Linezolid—Insomnia—Irinotecan—colon cancer	0.00251	0.00258	CcSEcCtD
Linezolid—Paraesthesia—Irinotecan—colon cancer	0.00249	0.00256	CcSEcCtD
Linezolid—Decreased appetite—Vincristine—colon cancer	0.00247	0.00255	CcSEcCtD
Linezolid—Dyspnoea—Irinotecan—colon cancer	0.00247	0.00254	CcSEcCtD
Linezolid—Erythema multiforme—Capecitabine—colon cancer	0.00247	0.00254	CcSEcCtD
Linezolid—Somnolence—Irinotecan—colon cancer	0.00246	0.00254	CcSEcCtD
Linezolid—Gastrointestinal disorder—Vincristine—colon cancer	0.00246	0.00253	CcSEcCtD
Linezolid—Fatigue—Vincristine—colon cancer	0.00245	0.00253	CcSEcCtD
Linezolid—Dyspepsia—Irinotecan—colon cancer	0.00244	0.00251	CcSEcCtD
Linezolid—Tinnitus—Capecitabine—colon cancer	0.00243	0.00251	CcSEcCtD
Linezolid—Pain—Vincristine—colon cancer	0.00243	0.00251	CcSEcCtD
Linezolid—Constipation—Vincristine—colon cancer	0.00243	0.00251	CcSEcCtD
Linezolid—Decreased appetite—Irinotecan—colon cancer	0.00241	0.00248	CcSEcCtD
Linezolid—Eosinophilia—Methotrexate—colon cancer	0.0024	0.00248	CcSEcCtD
Linezolid—Insomnia—Fluorouracil—colon cancer	0.0024	0.00247	CcSEcCtD
Linezolid—Gastrointestinal disorder—Irinotecan—colon cancer	0.00239	0.00246	CcSEcCtD
Linezolid—Fatigue—Irinotecan—colon cancer	0.00239	0.00246	CcSEcCtD
Linezolid—Paraesthesia—Fluorouracil—colon cancer	0.00238	0.00245	CcSEcCtD
Linezolid—Pancreatitis—Methotrexate—colon cancer	0.00238	0.00245	CcSEcCtD
Linezolid—Constipation—Irinotecan—colon cancer	0.00237	0.00244	CcSEcCtD
Linezolid—Pain—Irinotecan—colon cancer	0.00237	0.00244	CcSEcCtD
Linezolid—Dyspnoea—Fluorouracil—colon cancer	0.00237	0.00244	CcSEcCtD
Linezolid—Somnolence—Fluorouracil—colon cancer	0.00236	0.00243	CcSEcCtD
Linezolid—Chills—Capecitabine—colon cancer	0.00234	0.00241	CcSEcCtD
Linezolid—Dyspepsia—Fluorouracil—colon cancer	0.00234	0.00241	CcSEcCtD
Linezolid—Gastrointestinal pain—Vincristine—colon cancer	0.00233	0.0024	CcSEcCtD
Linezolid—Decreased appetite—Fluorouracil—colon cancer	0.00231	0.00238	CcSEcCtD
Linezolid—Pancytopenia—Methotrexate—colon cancer	0.0023	0.00238	CcSEcCtD
Linezolid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00229	0.00236	CcSEcCtD
Linezolid—Erythema—Capecitabine—colon cancer	0.00227	0.00234	CcSEcCtD
Linezolid—Neutropenia—Methotrexate—colon cancer	0.00227	0.00234	CcSEcCtD
Linezolid—Pain—Fluorouracil—colon cancer	0.00227	0.00234	CcSEcCtD
Linezolid—Gastrointestinal pain—Irinotecan—colon cancer	0.00227	0.00233	CcSEcCtD
Linezolid—Upper respiratory tract infection—Methotrexate—colon cancer	0.00226	0.00232	CcSEcCtD
Linezolid—Abdominal pain—Vincristine—colon cancer	0.00225	0.00232	CcSEcCtD
Linezolid—Body temperature increased—Vincristine—colon cancer	0.00225	0.00232	CcSEcCtD
Linezolid—Flatulence—Capecitabine—colon cancer	0.00224	0.00231	CcSEcCtD
Linezolid—Dysgeusia—Capecitabine—colon cancer	0.00222	0.00229	CcSEcCtD
Linezolid—Abdominal pain—Irinotecan—colon cancer	0.00219	0.00226	CcSEcCtD
Linezolid—Body temperature increased—Irinotecan—colon cancer	0.00219	0.00226	CcSEcCtD
Linezolid—Muscle spasms—Capecitabine—colon cancer	0.00218	0.00225	CcSEcCtD
Linezolid—Pneumonia—Methotrexate—colon cancer	0.00218	0.00224	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00215	0.00221	CcSEcCtD
Linezolid—Vision blurred—Capecitabine—colon cancer	0.00214	0.00221	CcSEcCtD
Linezolid—Renal failure—Methotrexate—colon cancer	0.00213	0.00219	CcSEcCtD
Linezolid—Stomatitis—Methotrexate—colon cancer	0.00211	0.00217	CcSEcCtD
Linezolid—Urticaria—Fluorouracil—colon cancer	0.00211	0.00217	CcSEcCtD
Linezolid—Anaemia—Capecitabine—colon cancer	0.0021	0.00216	CcSEcCtD
Linezolid—Body temperature increased—Fluorouracil—colon cancer	0.0021	0.00216	CcSEcCtD
Linezolid—Vertigo—Capecitabine—colon cancer	0.00204	0.0021	CcSEcCtD
Linezolid—Asthenia—Vincristine—colon cancer	0.00204	0.0021	CcSEcCtD
Linezolid—Leukopenia—Capecitabine—colon cancer	0.00203	0.0021	CcSEcCtD
Linezolid—Asthenia—Irinotecan—colon cancer	0.00199	0.00205	CcSEcCtD
Linezolid—Cough—Capecitabine—colon cancer	0.00198	0.00204	CcSEcCtD
Linezolid—Hypertension—Capecitabine—colon cancer	0.00196	0.00202	CcSEcCtD
Linezolid—Haemoglobin—Methotrexate—colon cancer	0.00195	0.00201	CcSEcCtD
Linezolid—Diarrhoea—Vincristine—colon cancer	0.00195	0.00201	CcSEcCtD
Linezolid—Haemorrhage—Methotrexate—colon cancer	0.00194	0.002	CcSEcCtD
Linezolid—Pharyngitis—Methotrexate—colon cancer	0.00193	0.00199	CcSEcCtD
Linezolid—Diarrhoea—Irinotecan—colon cancer	0.0019	0.00195	CcSEcCtD
Linezolid—Dry mouth—Capecitabine—colon cancer	0.00189	0.00195	CcSEcCtD
Linezolid—Dizziness—Vincristine—colon cancer	0.00188	0.00194	CcSEcCtD
Linezolid—Pruritus—Fluorouracil—colon cancer	0.00188	0.00193	CcSEcCtD
Linezolid—Erythema multiforme—Methotrexate—colon cancer	0.00184	0.00189	CcSEcCtD
Linezolid—Dizziness—Irinotecan—colon cancer	0.00183	0.00189	CcSEcCtD
Linezolid—Diarrhoea—Fluorouracil—colon cancer	0.00182	0.00187	CcSEcCtD
Linezolid—Thrombocytopenia—Capecitabine—colon cancer	0.00182	0.00187	CcSEcCtD
Linezolid—Tinnitus—Methotrexate—colon cancer	0.00181	0.00187	CcSEcCtD
Linezolid—Vomiting—Vincristine—colon cancer	0.00181	0.00186	CcSEcCtD
Linezolid—Skin disorder—Capecitabine—colon cancer	0.0018	0.00186	CcSEcCtD
Linezolid—Rash—Vincristine—colon cancer	0.00179	0.00185	CcSEcCtD
Linezolid—Hyperhidrosis—Capecitabine—colon cancer	0.00179	0.00185	CcSEcCtD
Linezolid—Dermatitis—Vincristine—colon cancer	0.00179	0.00185	CcSEcCtD
Linezolid—Headache—Vincristine—colon cancer	0.00178	0.00184	CcSEcCtD
Linezolid—Anorexia—Capecitabine—colon cancer	0.00177	0.00182	CcSEcCtD
Linezolid—Vomiting—Irinotecan—colon cancer	0.00176	0.00181	CcSEcCtD
Linezolid—Dizziness—Fluorouracil—colon cancer	0.00175	0.00181	CcSEcCtD
Linezolid—Rash—Irinotecan—colon cancer	0.00175	0.0018	CcSEcCtD
Linezolid—Dermatitis—Irinotecan—colon cancer	0.00174	0.0018	CcSEcCtD
Linezolid—Chills—Methotrexate—colon cancer	0.00174	0.0018	CcSEcCtD
Linezolid—Headache—Irinotecan—colon cancer	0.00174	0.00179	CcSEcCtD
Linezolid—Erythema—Methotrexate—colon cancer	0.00169	0.00174	CcSEcCtD
Linezolid—Nausea—Vincristine—colon cancer	0.00169	0.00174	CcSEcCtD
Linezolid—Vomiting—Fluorouracil—colon cancer	0.00169	0.00174	CcSEcCtD
Linezolid—Insomnia—Capecitabine—colon cancer	0.00168	0.00173	CcSEcCtD
Linezolid—Rash—Fluorouracil—colon cancer	0.00167	0.00172	CcSEcCtD
Linezolid—Dermatitis—Fluorouracil—colon cancer	0.00167	0.00172	CcSEcCtD
Linezolid—Paraesthesia—Capecitabine—colon cancer	0.00166	0.00172	CcSEcCtD
Linezolid—Headache—Fluorouracil—colon cancer	0.00166	0.00171	CcSEcCtD
Linezolid—Dysgeusia—Methotrexate—colon cancer	0.00166	0.00171	CcSEcCtD
Linezolid—Dyspnoea—Capecitabine—colon cancer	0.00165	0.0017	CcSEcCtD
Linezolid—Nausea—Irinotecan—colon cancer	0.00165	0.0017	CcSEcCtD
Linezolid—Dyspepsia—Capecitabine—colon cancer	0.00163	0.00168	CcSEcCtD
Linezolid—Decreased appetite—Capecitabine—colon cancer	0.00161	0.00166	CcSEcCtD
Linezolid—Gastrointestinal disorder—Capecitabine—colon cancer	0.0016	0.00165	CcSEcCtD
Linezolid—Fatigue—Capecitabine—colon cancer	0.0016	0.00165	CcSEcCtD
Linezolid—Vision blurred—Methotrexate—colon cancer	0.00159	0.00164	CcSEcCtD
Linezolid—Constipation—Capecitabine—colon cancer	0.00159	0.00163	CcSEcCtD
Linezolid—Pain—Capecitabine—colon cancer	0.00159	0.00163	CcSEcCtD
Linezolid—Nausea—Fluorouracil—colon cancer	0.00158	0.00162	CcSEcCtD
Linezolid—Anaemia—Methotrexate—colon cancer	0.00156	0.00161	CcSEcCtD
Linezolid—Vertigo—Methotrexate—colon cancer	0.00152	0.00157	CcSEcCtD
Linezolid—Gastrointestinal pain—Capecitabine—colon cancer	0.00152	0.00156	CcSEcCtD
Linezolid—Leukopenia—Methotrexate—colon cancer	0.00151	0.00156	CcSEcCtD
Linezolid—Cough—Methotrexate—colon cancer	0.00148	0.00152	CcSEcCtD
Linezolid—Urticaria—Capecitabine—colon cancer	0.00147	0.00152	CcSEcCtD
Linezolid—Abdominal pain—Capecitabine—colon cancer	0.00147	0.00151	CcSEcCtD
Linezolid—Body temperature increased—Capecitabine—colon cancer	0.00147	0.00151	CcSEcCtD
Linezolid—Convulsion—Methotrexate—colon cancer	0.00147	0.00151	CcSEcCtD
Linezolid—Anaphylactic shock—Methotrexate—colon cancer	0.00138	0.00142	CcSEcCtD
Linezolid—Thrombocytopenia—Methotrexate—colon cancer	0.00135	0.00139	CcSEcCtD
Linezolid—Skin disorder—Methotrexate—colon cancer	0.00134	0.00138	CcSEcCtD
Linezolid—Hyperhidrosis—Methotrexate—colon cancer	0.00133	0.00137	CcSEcCtD
Linezolid—Asthenia—Capecitabine—colon cancer	0.00133	0.00137	CcSEcCtD
Linezolid—Anorexia—Methotrexate—colon cancer	0.00132	0.00136	CcSEcCtD
Linezolid—Pruritus—Capecitabine—colon cancer	0.00131	0.00135	CcSEcCtD
Linezolid—Diarrhoea—Capecitabine—colon cancer	0.00127	0.00131	CcSEcCtD
Linezolid—Insomnia—Methotrexate—colon cancer	0.00125	0.00129	CcSEcCtD
Linezolid—Paraesthesia—Methotrexate—colon cancer	0.00124	0.00128	CcSEcCtD
Linezolid—Dyspnoea—Methotrexate—colon cancer	0.00123	0.00127	CcSEcCtD
Linezolid—Somnolence—Methotrexate—colon cancer	0.00123	0.00126	CcSEcCtD
Linezolid—Dizziness—Capecitabine—colon cancer	0.00123	0.00126	CcSEcCtD
Linezolid—Dyspepsia—Methotrexate—colon cancer	0.00121	0.00125	CcSEcCtD
Linezolid—Decreased appetite—Methotrexate—colon cancer	0.0012	0.00124	CcSEcCtD
Linezolid—Gastrointestinal disorder—Methotrexate—colon cancer	0.00119	0.00123	CcSEcCtD
Linezolid—Fatigue—Methotrexate—colon cancer	0.00119	0.00123	CcSEcCtD
Linezolid—Pain—Methotrexate—colon cancer	0.00118	0.00122	CcSEcCtD
Linezolid—Vomiting—Capecitabine—colon cancer	0.00118	0.00121	CcSEcCtD
Linezolid—Rash—Capecitabine—colon cancer	0.00117	0.0012	CcSEcCtD
Linezolid—Dermatitis—Capecitabine—colon cancer	0.00117	0.0012	CcSEcCtD
Linezolid—Headache—Capecitabine—colon cancer	0.00116	0.0012	CcSEcCtD
Linezolid—Gastrointestinal pain—Methotrexate—colon cancer	0.00113	0.00116	CcSEcCtD
Linezolid—Nausea—Capecitabine—colon cancer	0.0011	0.00113	CcSEcCtD
Linezolid—Urticaria—Methotrexate—colon cancer	0.0011	0.00113	CcSEcCtD
Linezolid—Body temperature increased—Methotrexate—colon cancer	0.00109	0.00112	CcSEcCtD
Linezolid—Abdominal pain—Methotrexate—colon cancer	0.00109	0.00112	CcSEcCtD
Linezolid—Asthenia—Methotrexate—colon cancer	0.00099	0.00102	CcSEcCtD
Linezolid—Pruritus—Methotrexate—colon cancer	0.000976	0.00101	CcSEcCtD
Linezolid—Diarrhoea—Methotrexate—colon cancer	0.000944	0.000973	CcSEcCtD
Linezolid—Dizziness—Methotrexate—colon cancer	0.000913	0.00094	CcSEcCtD
Linezolid—Vomiting—Methotrexate—colon cancer	0.000878	0.000904	CcSEcCtD
Linezolid—Rash—Methotrexate—colon cancer	0.00087	0.000897	CcSEcCtD
Linezolid—Dermatitis—Methotrexate—colon cancer	0.000869	0.000896	CcSEcCtD
Linezolid—Headache—Methotrexate—colon cancer	0.000865	0.000891	CcSEcCtD
Linezolid—Nausea—Methotrexate—colon cancer	0.00082	0.000845	CcSEcCtD
